Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Secures $7.45M in Highly Dilutive Pre-Paid Equity Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.1
Mkt Cap
$3.704M
52W Low
$1.02
52W High
$129.36
52W Position info
7.8% above low
Off High info
99% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

ELAB is trading near its 52-week low of $1.02 (7.8% above the low) on light trading volume (0.1× avg).

Summary

PMGC Holdings Inc. has consummated a $7.45 million secured pre-paid equity purchase, providing significant capital but under highly dilutive terms tied to future stock prices.


Key Events · Financing and Capital Events · ELAB

  • Secured $7.45 Million Financing

    The company consummated a 'Secured Pre-Paid Purchase #4' for a purchase price of $7,455,000.00, with $6,343,194.44 deposited into a newly formed subsidiary's controlled account.

  • Highly Dilutive Terms

    The investor can acquire shares at 88% of the lowest volume-weighted average price (VWAP) over a 10-day period, indicating substantial future dilution for existing shareholders.

  • Punitive Conditions

    The agreement includes a 120% prepayment penalty and an 18% annual interest rate upon an event of default, highlighting the aggressive nature of the financing.

  • Secured by Subsidiary Assets

    The financing is secured by cash in a deposit account and other collateral documents, including a guaranty from a newly formed wholly-owned subsidiary, ELAB Opportunity Holdings LLC.


Analysis · ELAB · Life Sciences

This 8-K reports the consummation of the Fourth Pre-Paid Purchase, a material financing agreement that injects $7.455 million in cash into PMGC Holdings Inc., with over $6.3 million deposited into a subsidiary's controlled account. While this represents a substantial capital infusion for a micro-cap company, the terms are highly unfavorable. The investor can purchase shares at an 88% discount to the lowest VWAP over a 10-day period, leading to significant potential dilution for existing shareholders. Additionally, the agreement includes a 120% prepayment penalty and an 18% annual interest rate upon an event of default, highlighting the aggressive nature of the financing. This financing provides critical liquidity and extends the operational runway, but at a very high cost to existing shareholders through future dilution and punitive terms. This follows the 424B5 filing on February 17, 2026, which registered a portion of the shares for this facility.

At the time of this filing, ELAB was trading at $1.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.7M. The 52-week trading range was $1.02 to $129.36. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Jul 07, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $1.08 info
Change: -$0.120 (-10%) info
Market Cap: $5.089M info
ELAB
Jul 06, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $1.08 info
Change: -$0.2487 (-19%) info
Market Cap: $5.089M info
ELAB
Jul 01, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $1.08 info
Change: -$0.490 (-31%) info
Market Cap: $5.089M info
ELAB
Jul 01, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.28
Real-time Price: $1.08 info
Change: -$0.200 (-16%) info
Market Cap: $5.089M info
ELAB
Jun 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $1.08 info
Change: -$0.400 (-27%) info
Market Cap: $5.089M info
ELAB
Jun 08, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.56
Real-time Price: $1.08 info
Change: -$0.480 (-31%) info
Market Cap: $5.089M info
ELAB
Jun 08, 2026, 7:31 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.79
Real-time Price: $1.08 info
Change: -$0.710 (-40%) info
Market Cap: $5.089M info
ELAB
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $1.08 info
Change: -$0.440 (-29%) info
Market Cap: $5.089M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.08 info
Change: -$0.730 (-40%) info
Market Cap: $5.089M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.08 info
Change: -$0.730 (-40%) info
Market Cap: $5.089M info